Sabine Mueller

Publications

3 shown

Figure 3 from Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

Diana Carvalho , Peter J. Richardson , Nagore G. Olaciregui +27 more

Synergy of combined vandetanib and everolimus in vitro. A, Cell viability matrix for ACVR1R206H</...

2025 0 citations

Figure 2 from Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

Diana Carvalho , Peter J. Richardson , Nagore G. Olaciregui +27 more

Validation of vandetanib as an ACVR1 inhibitor and everolimus as a P-gp inhibitor. A, Kinome selectivity map for vandetanib at 10 μmol/L, with red ci...

2025 0 citations

Supplementary Figures S1-S3 from Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

Diana Carvalho , Peter J. Richardson , Nagore G. Olaciregui +27 more

Supplementary Figures S1-S3

2025 0 citations

Frequent Co-Authors

Diana Carvalho

Peter J. Richardson

BenevolentAI (United Kingdom)

Nagore G. Olaciregui

Reda Stankunaite

Cinzia Lavarino

Valeria Molinari

Researcher Info

h-index: 0
Publications: 3
Citations: 0

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8216-9357

Impact Metrics

h-index 0

h-index: Number of publications with at least h citations each.

Publications

Figure 3 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma

Figure 2 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma

Supplementary Figures S1-S3 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma

Frequent Co-Authors

Diana Carvalho

Peter J. Richardson

Nagore G. Olaciregui

Reda Stankunaite

Cinzia Lavarino

Valeria Molinari

Researcher Info

External Links

Identifiers

Impact Metrics

Academic Output Over Time